Boron Neutron Capture Therapy (BNCT) Market Research Report 2024 | Valuates Reports

Boron Neutron Capture Therapy (BNCT) Market Size

According to new survey, global Boron Neutron Capture Therapy (BNCT) market is projected to reach US$ 2090.2 million in 2029, increasing from US$ 96.6 million in 2022, with the CAGR of 51.3% during the period of 2023 to 2029.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-11S15473/Global_Boron_Neutron_Capture_Therapy_BNCT_Market_Insights_Forecast_to_2029

Boron Neutron Capture Therapy (BNCT) Market Trends

The market for boron neutron capture therapy (BNCT) is expanding due to a number of important considerations. First off, BNCT presents a viable therapeutic alternative for some cancer kinds, especially those that don't respond well to traditional treatments. Using substances that include boron, BNCT specifically targets cancer cells. Next, the cells are exposed to low-energy neutrons, which causes the emission of high-energy alpha particles that kill the cancer cells while causing the least amount of harm to the surrounding healthy tissue. The market for BNCT-related goods and services is driven by the ongoing need for efficient cancer therapies, which makes BNCT an invaluable tool in the therapeutic toolbox.

The effectiveness and viability of BNCT have been enhanced by developments in neutron sources and boron delivery agents, opening up new avenues for patients and healthcare professionals to access this treatment. The logistical difficulties posed by conventional neutron sources have been lessened by the development of compact neutron sources, such as accelerators and compact reactors, allowing BNCT to be used in more healthcare institutions worldwide. Furthermore, by increasing treatment results and lowering potential adverse effects, continuing research efforts to improve tumor targeting capabilities and optimize boron delivery agents further assist to the growth of the BNCT market.

Boron Neutron Capture Therapy (BNCT) Market Share

The BNCT market is significant in North America, especially in the United States, because of reputable research institutes, powerful healthcare systems, and substantial government funding for cancer research. Leading biotechnology and pharmaceutical firms that specialize in oncology are also present, which propels market expansion in this area. Research partnerships and clinical trials help to develop BNCT technologies and increase their use in the treatment of cancer.

By Type
• Equipment
• Solution
• Drug

By Application
• Head and Neck Cancer
• Brain Tumor

Key Players
Neutron Therapeutics, Sumitomo Heavy Industries, International Particle Therapy Inc (IPT), RaySearch, Neuboron Medtech, TAE Life Sciences, Stella Pharma

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-11S15473/global-boron-neutron-capture-therapy-bnct

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.